닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Paris Massimo]

985건 중 985건 출력

, 92/99 페이지

  • 911
    The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “<i>indolent</i>” stage IV disease (Stage IV<sub>indolent</sub>).
    Davis, Andrew A.; Pierga, Jean-Yves; Dirix, Luc Yves; Michiels, Stefan; Rademaker, Alfred; Reuben, James M.; Fehm, Tanja N.; Munzone, Elisabetta; Giuliano, Mario; Vidal-Martinez, Jose; Mavroudis, Dimitrios; Grisanti, Salvatore; Generali, Daniele Giulio; Garcia-Saenz, Jose Angel; Stebbing, Justin; Dawson, Sarah-Jane; Gazzaniga, Paola; Bidard, Franç ois-Clé ment; Cristofanilli, Massimo; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL; ; Institut Curie, Paris, France; ; Translational Cancer Research Unit (TCRU), Oncologisch Centrum GZA, GZA St Augustinus, Antwerp, Belgium; ; Institut Gustave Roussy, Villejuif, France; ; Northwestern University Feinberg School of Medicine, Chicago, IL; ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; ; University of Duesseldorf, Duesseldorf, Germany; ; European Institute of Oncology, Milan, Italy; ; AOU Federico II, Naples, Italy; ; Hospital Arnau de Vilanova de Valencia, Valencia, Spain; ; Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece; ; Spedali Civili di Brescia, Brescia, BS, Italy; ; Istituti Osp.di Cremona, Cremona, Italy; ; Hospital Clí nico San Carlos; GEICAM Spanish Breast Cancer Group, Madrid, Spain; ; Imperial College Healthcare NHS Trust, London, United Kingdom; ; Pe; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.1019-1019)
  • 912
    Epizootic Haemorrhagic Disease Virus Serotype 8 in Tunisia, 2021
    Sghaier, Soufien; Sailleau, Corinne; Marcacci, Maurilia; Thabet, Sarah; Curini, Valentina; Ben Hassine, Thameur; Teodori, Liana; Portanti, Ottavio; Hammami, Salah; Jurisic, Lucija; Spedicato, Massimo; Postic, Lydie; Gazani, Ines; Ben Osman, Raja; Zientara, Stephan; Bré ard, Emmanuel; Calistri, Paolo; Richt, Jü rgen A.; Holmes, Edward C.; Savini, Giovanni; Di Giallonardo, Francesca; Lorusso, Alessio; Institut de la Recherche Vé té rinaire de Tunisie, Tunis 1006, Tunisia; UMR VIROLOGIE, INRAE, É cole Nationale Vé té rinaire d’Alfort, ANSES Laboratoire de Santé Animale, Université Paris-Est, 94700 Maisons-Alfort, France; Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy; Institut de la Recherche Vé té rinaire de Tunisie, Tunis 1006, Tunisia; Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy; Direction Gé né rale des Services Vé té rinaires, Commissariat Ré gional au Dé veloppement Agricole de Nabeul, Nabeul 1082, Tunisia; Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy; Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy; Service de Microbiologie, Immunologie et Pathologie Gé né rale, É cole Nationale de Mé decine; (Viruses, v.15, 2023, pp.16)
  • 913
    The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial
    Moretti, Claudio; Cerrato, Enrico; Cavallero, Erika; Lin, Song; Rossi, Marco Luciano; Picchi, Andrea; Sanguineti, Francesca; Ugo, Fabrizio; Palazzuoli, Alberto; Bertaina, Maurizio; Presbitero, Patrizia; Shao-liang, Chen; Pozzi, Roberto; Giammaria, Massimo; Limbruno, Ugo; Lefè vre, Thierry; Gasparetto, Valeria; Garbo, Roberto; Omedè , Pierluigi; Sheiban, Imad; Escaned, Javier; Biondi-Zoccai, Giuseppe; Gaita, Fiorenzo; Perl, Leor; D'Ascenzo, Fabrizio; Division of Cardiology, Città Della Salute e Della Scienza, Turin, Italy; Interventional Unit, University Hospital San Luigi Gonzaga, Orbassano and Rivoli Infermi Hospital, Rivoli (Turin), Italy; Division of Cardiology, Ospedale Civile SS. Annunziata, Savigliano (Cuneo), Italy; Department of Cardiology, Njang, China; Division of Cardiology, Istituto Clinico Humanitas, Rozzano, Milan, Italy; Division of Cardiology, Grosseto, Italy; Division of Cardiology, Massy, Paris, France; Division of Cardiology, Hospital Giovanni Bosco, Turin, Italy; Cardiovascular Diseases Unit Department of Internal Medicine, Le Scotte Hospital, University of Siena, Italy; Division of Cardiology, Città Della Salute e Della Scienza, Turin, Italy; Division of Cardiology, Istituto Clinico Humanitas, Rozzano, Milan, Italy; Department of Cardiology, Njang, China; Interventional Unit, University Hospital San Luigi Gonzaga, Orbassano and Rivoli Infermi Hospital, Rivoli (Turin), Italy; Division; (International journal of cardiology, v.257, 2018, pp.1-6)
  • 914
    Anomalous aortic origin of coronary arteries: Early results on clinical management from an international multicenter study
    Padalino, Massimo A.; Franchetti, Nicola; Sarris, George E.; Hazekamp, Mark; Carrel, Thierry; Frigiola, Alessandro; Horer, Jurgen; Roussin, Regine; Cleuziou, Julie; Meyns, Bart; Fragata, Jose; Telles, Helena; Polimenakos, Anastasios C.; Francois, Katrien; Veshti, Altin; Salminen, Jukka; Rocafort, Alvaro Gonzalez; Nosal, Matej; Vedovelli, Luca; Protopapas, Eleftherios; Tumbarello, Roberto; Merola, Assunta; Pegoraro, Cinzia; Motta, Raffaella; Boccuzzo, Giovanna; Sojak, Vladimir; Rito, Mauro Lo; Caldaroni, Federica; Corrado, Domenico; Basso, Cristina; Stellin, Giovanni; Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School; Section of Pediatric and Congenital Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Medical School; Athens Heart Surgery Institute and Iaso Children's Hospital; Department for Cardiovascular Surgery, University Medical Center; Department for Cardiovascular Surgery, University Hospital Bern and University of Bern; Department of Congenital Cardiac Surgery, IRCCS Policlinico San Donato; Department of Pediatric Cardiology and Congenital Heart Disease, Hô pital Marie Lannelongue, Université Paris-Sud; Department of Pediatric Cardiology and Congenital Heart Disease, Hô pital Marie Lannelong; (International journal of cardiology, v.291, 2019, pp.189-193)
  • 915
    Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
    Lansigan, Frederick; Horwitz, Steven M.; Pinter-Brown, Lauren C.; Rosen, Steven T.; Pro, Barbara; Hsi, Eric D.; Federico, Massimo; Gisselbrecht, Christian; Schwartz, Marc; Bellm, Lisa A.; Acosta, Mark; Shustov, Andrei R.; Advani, Ranjana H.; Feldman, Tatyana; Lechowicz, Mary Jo; Smith, Sonali M.; Tulpule, Anil; Craig, Michael D.; Greer, John P.; Kahl, Brad S.; Leach, Joseph W.; Morganstein, Neil; Casulo, Carla; Park, Steven I.; Foss, Francine M.; Dartmouth Hitchcock Medical Center, Hanover, New Hampshire, USA; Memorial Sloan-Kettering Cancer Center, New York, New York, USA; University of California, Irvine, Irvine, California, USA; City of Hope, Duarte, California, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA; Cleveland Clinic, Cleveland, Ohio, USA; Centro Oncologico Modenese, Policlinico, Modena, Italy; Hô pital Saint Louis, Paris, France; MS Biostatistics, LLC, Clermont, Florida, USA; MedNet Solutions, Minnetonka, Minnesota, USA; Spectrum Pharmaceuticals Inc., Irvine, California, USA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Stanford University Medical Center, Stanford, California, USA; Hackensack University Medical Center, Hackensack, New Jersey, USA; Emory University, Atlanta, Georgia, USA; University of Chicago, Chicago, Illinois, USA; University of Southern California, Los Angeles, California, USA; West Virginia University,; (Acta haematologica, v.143, 2020, pp.40-50)
  • 916
    Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
    Reetz, Kathrin; Hilgers, Ralf-Dieter; Isfort, Susanne; Dohmen, Marc; Didszun, Claire; Fedosov, Kathrin; Kistermann, Jennifer; Mariotti, Caterina; Durr, Alexandra; Boesch, Sylvia; Klopstock, Thomas; Rodrí guez de Rivera Garrido, Francisco Javier; Schö ls, Ludger; Klockgether, Thomas; Pandolfo, Massimo; Korinthenberg, Rudolf; Lavin, Philip; Molenberghs, Geert; Libri, Vincenzo; Giunti, Paola; Festenstein, Richard; Schulz, Jö rg B.; Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany; Department of Medical Statistics, RWTH Aachen University, Pauwelsstraße 19, Aachen, Germany; Center for Translational & Clinical Research Aachen (CTC-A), RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany; Center for Translational & Clinical Research Aachen (CTC-A), RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany; Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany; Department of Neurology, RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany; Center for Translational & Clinical Research Aachen (CTC-A), RWTH Aachen University, Pauwelsstraße 30, Aachen, Germany; Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Genetic Department, ICM (Brain and Spine Institute) Sorbonne Université s, UPMC University Paris 06 UMR S 1127, and INSERM; (Neurological research and practice, v.1, 2019, pp.33)
  • 917
    Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party
    Greco, Raffaella; Hoogenboom, Jorinde D.; Bonneville, Edouard F.; Anagnostopoulos, Achilles; Cuoghi, Angela; Dalle, Jean-Hugues; Weissinger, Eva M.; Lang, Peter; Galaverna, Federica; Martino, Massimo; Maschan, Alexei; Mauz-Kö rholz, Christine; Noviello, Maddalena; Passweg, Jakob; Peccatori, Jacopo; Rovira, Montserrat; Solano, Carlos; Veelken, Hendrik; Velardi, Andrea; Wagner-Drouet, Eva Maria; Zhang, Xi; Ciceri, Fabio; Bonini, Chiara; Vago, Luca; Ruggeri, Annalisa; Chabannon, Christian; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy; EBMT Leiden Study Unit, Leiden, The Netherlands; EBMT Leiden Study Unit, Leiden, The Netherlands; George Papanicolaou General Hospital, Thessaloniki, Greece; Azienda Ospedaliero Universitaria di Modena Policlinico, Modena, Italy; Hô pital Robert Debre, Paris, France; Hannover Medical School, Hannover, Germany; University Hospital, Tuebingen, Germany; IRRCS Ospedale Pediatrico Bambino Gesù , Rome, Italy; Grande Ospedale Metropolitano Bianchi Melacrino Morelli - Centro Unico Trapianti A. Neri, Reggio Calabria, Italy; Federal Research Center for Pediatric Hematology, Moscow, Russia; Justus-Liebig-University Giessen, Giessen, Germany; Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Disease, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milano, Italy; University Hospital, Basel, Sw; (Bone marrow transplantation, v.58, 2023, pp.603-606)
  • 918
    Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023
    Fontá n-Vela, Mario; Kissling, Esther; Nicolay, Nathalie; Braeye, Toon; Van Evercooren, Izaak; Holm Hansen, Christian; Emborg, Hanne-Dorthe; Fabiani, Massimo; Mateo-Urdiales, Alberto; AlKerwi, Ala'a; Schmitz, Susanne; Castilla, Jesú s; Martí nez-Baz, Ivá n; de Gier, Brechje; Hahné , Susan; Meijerink, Hinta; Starrfelt, Jostein; Nunes, Baltazar; Caetano, Constantino; Derrough, Tarik; Nardone, Anthony; Monge, Susana; Public Health and Epidemiology research group, School of Medicine and Health Sciences, Universidad de Alcalá , Alcalá de Henares, Madrid, Spain; Epiconcept, Paris, France; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; Sciensano, Elsene, Belgium; Sciensano, Elsene, Belgium; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark; Infectious Diseases Department, Istituto Superiore di Sanità , Rome, Italy; Infectious Diseases Department, Istituto Superiore di Sanità , Rome, Italy; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg; CIBER Epidemiologí a y Salud Pú blica; (Euro surveillance : bulletin europ&eacute;en sur les maladies transmissibles = European communicable disease bulletin, v.29, 2024, )
  • 919
    Propensity Score Matching Comparing Asciminib <i>Versus</i> Ponatinib in Chronic Myeloid Leukemia Patients Who Failed Prior Tyrosine Kinase Inhibitor Therapy
    Perusini, Maria Agustina; Kockerols, Camille; Ž á č ková , Daniela; Nicolini, Franck E.; Castagnetti, Fausto; Pavlovsky, Carolina; Breccia, Massimo; Rea, Delphine; Fava, Carmen; Savoie, Mary Lynn; Bouvier, Christophe; Č ič á tková , Petra; Bollard, Julien; Linn, Swe Mar; Gupta, Gopila; Scalzulli, Emilia; Mayer, Jiř í ; Westerweel, Peter E; Kim, Dennis Dong Hwan; 1Princess Margaret Cancer Centre / University Health Network, Toronto, Canada; 2Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands; 3Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic; 4Hematology Department, Centre Leon Berard, Lyon, France; 5Institute of Hematology “L. e A. Serà gnoli”, University of Bologna, Bologna, Italy; 6FUNDALEU, Buenos Aires, Argentina; 7Department of Translational and Precision Medicine, Hematology-Sapienza University, Rome, Italy; 8Hematology Department, Hô pital Saint-Louis, Paris, France; 9Department of Clinical and Biological Sciences, University of Turin, Torino, Italy, Orbassano, Italy; 10Foothills Medical Centre, Calgary, CAN; 11Fi-LMC group, Lyon, France; 12Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic; 4Hematology Department, Centre Leon Berard, Lyo; (Blood, v.142, 2023, pp.6360-6360)
  • 920
    Friedreich's ataxia: Point mutations and clinical presentation of compound heterozygotes
    Cossé e, Mireille; Dü rr, Alexandra; Schmitt, Michè le; Dahl, Niklas; Trouillas, Paul; Allinson, Patricia; Kostrzewa, Markus; Nivelon-Chevallier, Annie; Gustavson, Karl-Henrik; Kohlschü tter, Alfried; Mü ller, Ulrich; Mandel, Jean-Louis; Brice, Alexis; Koenig, Michel; Cavalcanti, Francesca; Tammaro, Angela; De Michele, Giuseppe; Filla, Alessandro; Cocozza, Sergio; Labuda, Malgorzata; Montermini, Laura; Poirier, José e; Pandolfo, Massimo; Institut de Gé né tique et de Biologie Molé culaire et Cellulaire (IGBMC), CNRS/INSERM/ULP, Hô pitaux Universitaires de Strasbourg, Illkirch, France; Fé dé ration de Neurologie and INSERM U289, Hô pital de la Salpé triè re, Paris, France; Institut de Gé né tique et de Biologie Molé culaire et Cellulaire (IGBMC), CNRS/INSERM/ULP, Hô pitaux Universitaires de Strasbourg, Illkirch, France; Department of Clinical Genetics, Uppsala University Children's Hospital, Uppsala, Sweden; Hô pitaux Neurologique et Neurochirurgical Pierre Wertheimer, Lyon, France; Division of Medical Genetics, Children's Medical Center, Charlottesville, VA; Justus-Liebig-Universitä t, Giessen, Germany; Centre de Gé né tique, Hô pital d'Enfants, Dijon, France; Department of Clinical Genetics, Uppsala University Children's Hospital, Uppsala, Sweden; Universitä ts-Krankenhaus Eppendorf, Kinderklinik, Hamburg,; (Annals of neurology, v.45, 1999, pp.200-206)

처음 오셨나요?